Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Revitalist Lifestyle and Wellness Ltd. C.CALM

Alternate Symbol(s):  RVLWF

Revitalist Lifestyle and Wellness Ltd. is a mental health company. The Company is primarily engaged in the provision of psychotherapy services. It provides ketamine-assisted psychotherapy and other treatments through its network of integrative mental health clinics. The Company’s segments include Clinical Operations and Research. Its Clinical Operations segment encompass the Company’s ketamine... see more

CSE:CALM - Post Discussion

Revitalist Lifestyle and Wellness Ltd. > Revitalist Increase National Footprint to 60,000 Square Feet
View:
Post by Betteryear2 on Feb 10, 2022 10:22am

Revitalist Increase National Footprint to 60,000 Square Feet

VANCOUVER, British Columbia--()--REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is pleased to announce it has formally opened its ninth psychedelic assisted psychotherapy clinic located at 6871 Belfort Oaks Place, Suite 2, Jacksonville, FL, 32216 (“Jacksonville Clinic”). With the opening of this clinic, Revitalist has a total clinic footprint of over 60,000 square feet and has become one of the largest publicly listed ketamine focused treatment chains in the U.S.

The Jacksonville Clinic is managed by Dr. Nicholas Kalynych and will transition patients from the acquisition previously announced on January 12, 2022. With 12 treatment rooms, the clinic can provide approximately 12,500 ketamine infusions to patients annually and currently offers ketamine infusions, vitamin infusions, Spravato and telemedicine therapy.

Dr. Nicholas Kalynych commented: “We are thrilled to formally open our doors to our existing patient base and welcome new faces to our beautiful facility. Our former clinic capacity was limited, so the availability of 12 treatment rooms will be instrumental in providing essential medical care to the Jacksonville community while facilitating incremental growth to the practice.”

Kathryn Walker, CEO of Revitalist, commented: “Revitalist has grown to 60,000 square feet of facility space and nine clinics in less than twelve months making us one of the largest publicly traded ketamine focused treatment chains in the U.S. in terms of facility space. In the coming months we intend to focus on perfecting our infrastructure and capitalizing on the economies of scale associated with the growth we have achieved to date. Our goal is to be leaders in this space, striving to do our part to improve global healthcare and bring value to our shareholders.”

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities